![Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00387-7/MediaObjects/13555_2020_387_Fig5_HTML.jpg)
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial | Dermatology and Therapy
![Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aa17520d-6052-4b4b-a2d2-f0128bfa0dc2/pde13622-fig-0001-m.jpg)
Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl - Cardis - 2018 - Pediatric Dermatology - Wiley Online Library
Combined Treatment of Disfiguring Facial Angiofibromas in Tuberous Sclerosis Complex With Surgical Debulking and Topical Sirolimus | MDedge Dermatology
![Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2015/81/5/Images/ijdvl_2015_81_5_540_163800_u1.jpg)
Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma - Indian Journal of Dermatology, Venereology and Leprology
![Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex](https://www.frontiersin.org/files/Articles/490613/fmed-07-00001-HTML/image_m/fmed-07-00001-g002.jpg)
Frontiers | Early Sirolimus Gel Treatment May Diminish Angiofibromas and Prevent Angiofibroma Recurrence in Children With Tuberous Sclerosis Complex
![Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962217304413-gr4.jpg)
Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex A Randomized Clinica
![Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//15782190/0000010500000008/v1_201409260034/S1578219014002017/v1_201409260034/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6Aq+/+tYSfrJHoIjA0ZsKBCmTzTtPJCcLdztuyjMF+NvJ9rOIL9Y+3V5/XfdcvEtaejTmkMV0R+wZIk5v8PqBgthSmEM1WnAJoNW3GtJYI95soZCcpEJ1372kM0WosVeLhQcqEjA06aDEU9GHrbrt4EXM5aMgZuqdHaJDcgylF84YlHtjSHZqroY1BCh5yJ8psumHNOyNteye23LW45Bsyxg=)
Topical 0.2% Rapamycin to Treat Facial Angiofibromas and Hypomelanotic Macules in Tuberous Sclerosis | Actas Dermo-Sifiliográficas
![PDF] Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar PDF] Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/63ab7bdd014faad450bc752dda72fdce3bf8d3b4/7-Figure4-1.png)
PDF] Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex: A Randomized Clinical Trial | Semantic Scholar
![Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News](https://www.rapamycin.news/uploads/default/original/2X/7/7712f90c5a4ddd0354f8e7fac7a25bb847e6618d.jpeg)
Rapamycin Skin Cream - US Pharmacy that is Selling it (prescription needed) - Rapamycin Longevity News
![Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-019-3767-8/MediaObjects/13063_2019_3767_Fig1_HTML.png)
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial | Trials | Full Text
![Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/5528/5528_20270.png)
Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review | HTML | Acta Dermato-Venereologica
I wanted to share something pretty awesome with you guys! Almost 2 and a half weeks ago, I received this sirolimus cream in the mail. I have been on the sirolimus pill
![Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect Long-term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962217304413-gr2.jpg)